Stockreport

Verastem Oncology Announces Closing of COPIKTRA® (duvelisib) Sale to Secura Bio

Verastem, Inc.  (VSTM) 
Last verastem, inc. earnings: 10/29 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF Verastem Now Focused on Development of VS-6766 and Defactinib Combination in Low-Grade Serous Ovarian Cancer and KRAS Mutant Non-Small Cell Lung CancerRegistration-Direc [Read more]